134 related articles for article (PubMed ID: 22869285)
1. Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study.
Villarini A; Pasanisi P; Raimondi M; Gargano G; Bruno E; Morelli D; Evangelista A; Curtosi P; Berrino F
Breast Cancer Res Treat; 2012 Sep; 135(2):581-9. PubMed ID: 22869285
[TBL] [Abstract][Full Text] [Related]
2. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
Gordon AM; Hurwitz S; Shapiro CL; LeBoff MS
Menopause; 2011 Nov; 18(11):1244-8. PubMed ID: 21814159
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet.
Thomson CA; Rock CL; Giuliano AR; Newton TR; Cui H; Reid PM; Green TL; Alberts DS;
Eur J Nutr; 2005 Feb; 44(1):18-25. PubMed ID: 15309460
[TBL] [Abstract][Full Text] [Related]
4. Energy balance in early breast cancer patients receiving adjuvant chemotherapy.
Harvie MN; Campbell IT; Baildam A; Howell A
Breast Cancer Res Treat; 2004 Feb; 83(3):201-10. PubMed ID: 14758090
[TBL] [Abstract][Full Text] [Related]
5. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S
J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
[TBL] [Abstract][Full Text] [Related]
7. Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer.
Campbell KL; Lane K; Martin AD; Gelmon KA; McKenzie DC
Cancer Nurs; 2007; 30(2):95-100. PubMed ID: 17413774
[TBL] [Abstract][Full Text] [Related]
8. Weight change trajectory in women with breast cancer receiving chemotherapy and the effect of different regimens.
Liu LN; Wen FH; Miaskowski C; Lin YC; Wang JS; Jeng C; Chen ML
J Clin Nurs; 2014 Oct; 23(19-20):2757-68. PubMed ID: 24393441
[TBL] [Abstract][Full Text] [Related]
9. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
McInnes JA; Knobf MT
Oncol Nurs Forum; 2001 May; 28(4):675-84. PubMed ID: 11383182
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.
Bicakli DH; Varol U; Degirmenci M; Tunali D; Cakar B; Durusoy R; Karaca B; Ali Sanli U; Uslu R
J Oncol Pharm Pract; 2016 Feb; 22(1):46-53. PubMed ID: 25233884
[TBL] [Abstract][Full Text] [Related]
11. Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?
Kumar N; Allen KA; Riccardi D; Bercu BB; Cantor A; Minton S; Balducci L; Jacobsen PB
Breast Cancer Res Treat; 2004 Jan; 83(2):149-59. PubMed ID: 14997046
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
13. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
[TBL] [Abstract][Full Text] [Related]
14. Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.
Torrisi R; Bagnardi V; Rotmensz N; Scarano E; Iorfida M; Veronesi P; Luini A; Viale G; Santoro A; Colleoni M; Goldhirsch A
Breast Cancer Res Treat; 2011 Apr; 126(2):431-41. PubMed ID: 21221766
[TBL] [Abstract][Full Text] [Related]
15. [Medical treatment of early breast cancer: chemotherapy].
Ejlertsen B; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
[TBL] [Abstract][Full Text] [Related]
16. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
[TBL] [Abstract][Full Text] [Related]
18. The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer.
Nolan L; Darby A; Boleti K; Simmonds P
Breast; 2011 Apr; 20(2):151-4. PubMed ID: 20970333
[TBL] [Abstract][Full Text] [Related]
19. [New methods in the treatment of breast cancer].
Semiglazov VF
Vopr Onkol; 1997; 43(1):22-6. PubMed ID: 9133082
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantrone, and fluorouracil in women with breast cancer.
Kumpulainen EJ; Hirvikoski PP; Johansson RT
Acta Oncol; 2008; 47(1):120-3. PubMed ID: 18097780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
